AllenT., & AudetD. (1994). Tetanus prophylaxis: Protocols require further change and simplification. Journal of Emergency Medicine, 11, 757–758.
2.
Arline v. St. Elizabeth Hospital, Texas, Jefferson County 136th Judicial District Court, No. #143,918, June 29, 1993. Law Reporter, 36, 376.
3.
BalestraD.J., & LittenbergB. (1993). Should adult tetanus immunization be given as a single vaccination at age 65?Journal of General Internal Medicine3, 405–412.
CroneN.E., & RederA.T. (1992). Severe tetanus in immunized patients with high anti-tetanus titers. Neurology, 42, 761–764.
6.
DeSouzaC.E.KarnadD.R., & TilveG.H. (1992). Clinical and bacteriological profile of the ear in otogenic tetanus: A case control study. Journal of Laryngology, 106, 1051–1054.
7.
FursteW. (1992). Tetanus prophylaxis in the United States. American College of Surgeons Bulletin, 77(8), 22–26.
8.
GroleauG. (1992). Tetanus. In OlshakerJ.S. & TekD. (Eds.). Emergency Medicine Clinics of North America: Environmental Emergencies, 10(2), 351–359.
9.
IsselbacherK.J.BraunwaldE.WilsonJ.D.MartinJ.B.FauciN.S., & KasperD.L. (1994). Harrison's principals of internal medicine (13th Ed.). New York: McGraw-Hill.
10.
Koda-KimbleM.A., & YoungL.Y. (1992). Applied therapeutics: The clinical use of drugs. Vancouver: Applied Therapeutics.
11.
LeonardD.A. (1800). Funeral sermon. New York: Furman and Lowden.
12.
LuistoM. (1980). Epidemiology of tetanus in Finland from 1969 to 1985. Scandinavian Journal of Infectious Disease, 21, 655–663.
13.
LuistoM., & SeppalainenA.M. (1992). Tetanus caused by occupational accidents. Scandinavian Journal of Work and Environmental Health, 18, 232–326.
14.
MiliauskasJ.R., & MukherjeeT. (1993). Postimmunization (vaccination) injection-site reactions: A report of four cases and review of the literature. American Journal of Surgical Pathology, 17(5),5516–5524.
15.
MontecuccoC., & SchiavoG. (1993). Tetanus and botulism neurotoxins: A new group of zinc proteases. Trends in Biochemical Sciences, 18(9), 324–239.
16.
MulhoolyJ.P. (1984). Tetanus immunization of adult members of an HMO. American Journal of Public Health, 74, 841–842.
17.
PassenE.L., & AndersenB.R. (1986). Clinical tetanus despite a “protective” level of toxin-neutralizing antibody. JAMA, 255(9), 1171–1173.
18.
SmithC.D. (1975). The pathogenic anaerobic bacteria. Minneapolis: C. Thomas.
19.
SneathP.T.KerslakeE.G., & ScrubyF. (1937). Tetanus immunity: The resistance of guinea pigs to lethal spore doses induced by active and passive immunization. American Journal of Hygiene, 25, 464–476.
20.
StairT.O.LippeM.A.RussellH., & FreeleyJ.C. (1989). Tetanus immunity in emergency department patients. American Journal of Emergency Medicine, 7, 563–566.
21.
SteinB.E. (1993). Adult vaccinations: Protecting your patients from avoidable illness. Geriatrics, 48(9), 46–55.
22.
SutterR.W.CochiS.L.BrinkE.W., & SirotkinB.I. (1990). Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979–1084. American Journal of Epidemiology, 131(1), 132–142.
U.S. Department of Health and Human Services (USDHHS). (1991). Diphtheria, tetanus, and pertussis: Recommendations for vaccine use and other preventive measures. Morbidity and Mortality Weekly Report, 40(RR-10), 2–3.
25.
USDHHS, Public Health Service. (1992a). Healthy people 2000: National health promotion and disease prevention objectives. Boston: Jones & Bartlett.
26.
USDHHS. (1992b). Tetanus-Rutland County, Vermont, 1992. Morbidity and Mortality Weekly Report, 41(39), 721–722.
27.
USDHHS. (1993). Comprehensive delivery of adult vaccination—Minnesota—1992. Morbidity and Mortality Weekly Report, 42(39), 68–70.
28.
WirzM.GentiliG., & CollottiC. (1990). Tetanus vaccine: Present status. In MizrahiA. (Ed.). Advances in biotechnological processes. New York: Wiley Liss.